Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$11.3K Buy
48
+2
+4% +$692 ﹤0.01% 1599
2024
Q4
$18.1K Hold
46
﹤0.01% 1339
2024
Q3
$15.4K Sell
46
-18
-28% -$4.96K ﹤0.01% 1443
2024
Q2
$15.6K Buy
64
+62
+3,100% +$16.3K ﹤0.01% 1389
2024
Q1
$697 Hold
2
﹤0.01% 2477
2023
Q4
$583 Sell
2
-2
-50% -$516 ﹤0.01% 2559
2023
Q3
$1.06K Sell
4
-1
-20% -$348 ﹤0.01% 2344
2023
Q2
$1.65K Sell
5
-1
-17% -$261 ﹤0.01% 2226
2023
Q1
$1.46K Sell
6
-13
-68% -$3.77K ﹤0.01% 2366
2022
Q4
$5.08K Buy
19
+2
+12% +$521 ﹤0.01% 1817
2022
Q3
$4K Buy
17
+3
+21% +$810 ﹤0.01% 1790
2022
Q2
$3K Buy
14
+5
+56% +$1.48K ﹤0.01% 1828
2022
Q1
$3K Buy
+9
New +$3.6K ﹤0.01% 1867

Other funds holding RH

Lindbrook Capital's RH Position: Q1 2025 in Review

Lindbrook Capital increased its RH (RH) stake by 4.3% in Q1 2025, buying an estimated $692 and bringing the position to 48 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1599.

Lindbrook Capital first reported a position in RH in Q1 2022 and has held it in 13 quarters since. The position peaked at $18.1K in Q4 2024. 391 funds tracked by Wall St. Rank hold RH as of Q1 2025.

  • Lindbrook Capital held 48 shares of RH worth $11.3K as of Q1 2025.
  • Lindbrook Capital bought 2 RH shares in Q1 2025, an estimated $692.
  • RH made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1599 holding.
  • Lindbrook Capital first reported a position in RH in Q1 2022 and has held it in 13 quarters since.
  • Lindbrook Capital's RH position peaked at $18.1K in Q4 2024.
  • 391 funds tracked by Wall St. Rank held RH as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.